Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health agencies, among other moves that have sent waves through the biopharma industry.

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based ...

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all ...

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

The US Department of Health and Human Services awards Moderna $590 million to continue developing a vaccine to protect against bird flu.

Following four straight sessions of gains, Moderna (NASDAQ:MRNA) shares continued to trade higher in the premarket on Friday after the company received a tender to supply its COVID-19 vaccine in the ...

The Sackler family, owners of Purdue Pharma, reached a $7.4 billion settlement to resolve mass opioid litigation. The Department of Justice filed a civil lawsuit against Walgreens over allegations it ...

The antibody from Chicago-based Immunartes is designed to neutralize the immune-evasive mechanisms of Staphylococcus aureus.

Following his speech, Trump signed a slew of executive orders—declaring a national emergency at the southern border and an end to birthright citizenship, as well as ending use of the CBP1 app, among ...

The exact degree of population declines, however, will depend on local hunter harvest and recruitment rates, the report authors say.